[SCHEDULE 13G YY Inc. (Name of Issuer) Class A Common Stock, $0.00001 par value per share (Title of Class of Securities) 98426T106 (CUSIP Number) August 18, 2016 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) x Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial]
[FORM 10-Q (Mark One) ☒ June 30, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[FORM 10-Q (Mark One) ☒ June 30, 2016 For the quarterly period ended: Or ☐ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Ronghua Wang EX-32.1 4 ex32-1.htm EX-32.1] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Qinghua Liu Qinghua Liu Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm EX-32.2]
[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION SMIC REPORTS UNAUDITED RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2016 Revenue was a record high of $690.2 million in 2Q16, an increase of 8.8% Set out below is a copy of the full text of the press release by the Company and its subsidiaries (the Group) on August 10, 2016, in relation to its] [FORM 6-K Semiconductor Manufacturing International Corporation 18 Zhangjiang Road x x n/a Semiconductor Manufacturing International Corporation Dr. Tzu-Yin Chiu Dr. Tzu-Yin Chiu Chief Executive Officer and Executive Director Description 99.1 Announcement dated 10 August 2016 “SMIC REPORTS UNAUDITED RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2016" 6-K 1 htm_10411.htm LIVE FILING]
[SEMICONDUCTOR MANUFACTURING INTERNATIONAL CORPORATION SMIC REPORTS UNAUDITED RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2016 Revenue was a record high of $690.2 million in 2Q16, an increase of 8.8% Set out below is a copy of the full text of the press release by the Company and its subsidiaries (the Group) on August 10, 2016, in relation to its] [FORM 6-K Semiconductor Manufacturing International Corporation 18 Zhangjiang Road x x n/a Semiconductor Manufacturing International Corporation Dr. Tzu-Yin Chiu Dr. Tzu-Yin Chiu Chief Executive Officer and Executive Director Description 99.1 Announcement dated 10 August 2016 “SMIC REPORTS UNAUDITED RESULTS FOR THE THREE MONTHS ENDED JUNE 30, 2016" 6-K 1 htm_10411.htm LIVE FILING]
[FORM 10−Q (Mark One) June 30, 2016 For the quarterly period ended: For the transition period from _____________ to _____________ 001-32898 CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park, Meigui Street Huayuankou Economic Zone Dalian City, Liaoning Province, China, 116450 (86)(411)-3918-5985 _____________________________________________________ Large accelerated filer [ ]] [CERTIFICATIONS I, Yunfei Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Wenwu Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Yunfei Li Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Wenwu Wang Interim Chief Financial Officer (Principal Financial and Accounting Officer)]
[FORM 10−Q (Mark One) June 30, 2016 For the quarterly period ended: For the transition period from _____________ to _____________ 001-32898 CHINA BAK BATTERY, INC. Nevada 88-0442833 (State or other jurisdiction of (I.R.S. Employer Identification No.) incorporation or organization) BAK Industrial Park, Meigui Street Huayuankou Economic Zone Dalian City, Liaoning Province, China, 116450 (86)(411)-3918-5985 _____________________________________________________ Large accelerated filer [ ]] [CERTIFICATIONS I, Yunfei Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [CERTIFICATIONS I, Wenwu Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of China BAK Battery, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Yunfei Li Chief Executive Officer] [OF THE SARBANES-OXLEY ACT OF 2002 2. Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company. nd Wenwu Wang Interim Chief Financial Officer (Principal Financial and Accounting Officer)]
[Xinyuan Real Estate Co., Ltd. and Subsidiaries CONTENTS Pages Condensed consolidated balance sheets as of December 31, 2015 (audited) and June 30, 2016 (unaudited) F-2 Condensed consolidated statements of comprehensive income for the six months ended June 30, 2015 and 2016 (unaudited) F-4 Condensed consolidated statements of cash flows for the six months ended June 30, 2015 and 2016 (unaudited)] [Selected financial data Our Selected Consolidated Financial Data The selected consolidated financial data should be read in conjunction with, and are qualified in their entirety by reference to, our unaudited condensed consolidated financial statements and related notes and the "Operating and Financial Review and Prospects” included elsewhere in this report. Six months ended June 30, 2015 2016 US$ US$ (Unaudited)] [OPERATING AND FINANCIAL REVIEW AND PROSPECTS A. Operating Results Overview Our total revenue, derived primarily from sales of residential real estate, has increased from US$441.8 million in the first six months of 2015 to US$612.0 million in the first six months of 2016. Our net income was US$24.7 million and US$32.6 million, respectively, for the same periods. We acquire land] []
[Xinyuan Real Estate Co., Ltd. and Subsidiaries CONTENTS Pages Condensed consolidated balance sheets as of December 31, 2015 (audited) and June 30, 2016 (unaudited) F-2 Condensed consolidated statements of comprehensive income for the six months ended June 30, 2015 and 2016 (unaudited) F-4 Condensed consolidated statements of cash flows for the six months ended June 30, 2015 and 2016 (unaudited)] [Selected financial data Our Selected Consolidated Financial Data The selected consolidated financial data should be read in conjunction with, and are qualified in their entirety by reference to, our unaudited condensed consolidated financial statements and related notes and the "Operating and Financial Review and Prospects” included elsewhere in this report. Six months ended June 30, 2015 2016 US$ US$ (Unaudited)] [OPERATING AND FINANCIAL REVIEW AND PROSPECTS A. Operating Results Overview Our total revenue, derived primarily from sales of residential real estate, has increased from US$441.8 million in the first six months of 2015 to US$612.0 million in the first six months of 2016. Our net income was US$24.7 million and US$32.6 million, respectively, for the same periods. We acquire land] []
[FORM 10-Q (Mark One) June 30, 2016 For the quarterly period ended: 001-34449 Commission File No. AMERICAN LORAIN CORPORATION Nevada 87-0430320 (State or other jurisdiction of (I.R.S. Employer incorporation or organization) Identification No.) BeihuanZhong Road Junan County Shandong, Peoples Republic of China, 276600 (86) 539-7317959 Large accelerated filer [_] Accelerated filer [_] Non-accelerated filer [_] Smaller reporting company [X] (Do] [CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER I, Si Chen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation. 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATIONS OF CHIEF FINANCIAL OFFICER I, Zhanhai Yang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q for the period ended June 30, 2016 of American Lorain Corporation 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.]
